APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Anti-Infective Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global OTC Anti-Infective Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026196 pages

Choose your research edition.

Industry ResearchOTC Anti-Infective Drug Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Anti-Infective Drug Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal OTC Anti-Infective Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Anti-Infective Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Anti-Infective Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global OTC Anti-Infective Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for OTC Anti-Infective Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for OTC Anti-Infective Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OTC Anti-Infective Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for OTC Anti-Infective Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of OTC Anti-Infective Drug include Cipla, CR SANJIU, Lingrui, Sun Pharma, Bayer, GSK, MYLAN, NOVARTIS and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global OTC Anti-Infective Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of OTC Anti-Infective Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents OTC Anti-Infective Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the OTC Anti-Infective Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

OTC Anti-Infective Drug Segment by Company

Cipla

CR SANJIU

Lingrui

Sun Pharma

Bayer

GSK

MYLAN

NOVARTIS

Johnson & Johnson

Teva

OTC Anti-Infective Drug Segment by Type

Antiviral

Antibacterial

Antifungal

Antiseptics

Other

OTC Anti-Infective Drug Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

OTC Anti-Infective Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Anti-Infective Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Anti-Infective Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Anti-Infective Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of OTC Anti-Infective Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global OTC Anti-Infective Drug industry.

Chapter 3: Detailed analysis of OTC Anti-Infective Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, OTC Anti-Infective Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global OTC Anti-Infective Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Antiviral Table 3. Key Players of Antibacterial Table 4. Key Players of Antifungal Table 3. Key Players of Antiseptics Table 4. Key Players of Other Table 5. Global OTC Anti-Infective Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Retail Pharmacies Table 7. Key Players of Online Pharmacies Table 8. Key Players of Hospital Pharmacies Table 9. Global OTC Anti-Infective Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global OTC Anti-Infective Drug Market Size by Region (2021-2026) & (US$ Million) Table 11. Global OTC Anti-Infective Drug Market Share by Region (2021-2026) Table 12. Global OTC Anti-Infective Drug Market Size by Region (2027-2032) & (US$ Million) Table 13. Global OTC Anti-Infective Drug Market Share by Region (2027-2032) Table 14. OTC Anti-Infective Drug Industry Trends Table 15. OTC Anti-Infective Drug Industry Drivers Table 16. OTC Anti-Infective Drug Industry Opportunities and Challenges Table 17. OTC Anti-Infective Drug Industry Restraints Table 18. Global OTC Anti-Infective Drug Revenue by Company (US$ Million) & (2021-2026) Table 19. Global OTC Anti-Infective Drug Revenue Market Share by Company (2021-2026) Table 20. Global OTC Anti-Infective Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global OTC Anti-Infective Drug Key Company Head Office and Area Served Table 22. Global OTC Anti-Infective Drug Company, Product Type & Application Table 23. Global OTC Anti-Infective Drug Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global OTC Anti-Infective Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global OTC Anti-Infective Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global OTC Anti-Infective Drug Market Size by Type (2021-2026) & (US$ Million) Table 28. Global OTC Anti-Infective Drug Market Size by Type (2027-2032) & (US$ Million) Table 29. Global OTC Anti-Infective Drug Revenue Market Share by Type (2021-2026) Table 30. Global OTC Anti-Infective Drug Revenue Market Share by Type (2027-2032) Table 31. Global OTC Anti-Infective Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global OTC Anti-Infective Drug Market Size by Application (2021-2026) & (US$ Million) Table 33. Global OTC Anti-Infective Drug Market Size by Application (2027-2032) & (US$ Million) Table 34. Global OTC Anti-Infective Drug Revenue Market Share by Application (2021-2026) Table 35. Global OTC Anti-Infective Drug Revenue Market Share by Application (2027-2032) Table 36. Cipla Company Information Table 37. Cipla Business Overview Table 38. Cipla OTC Anti-Infective Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Cipla OTC Anti-Infective Drug Product Portfolio Table 40. Cipla Recent Development Table 41. CR SANJIU Company Information Table 42. CR SANJIU Business Overview Table 43. CR SANJIU OTC Anti-Infective Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. CR SANJIU OTC Anti-Infective Drug Product Portfolio Table 45. CR SANJIU Recent Development Table 46. Lingrui Company Information Table 47. Lingrui Business Overview Table 48. Lingrui OTC Anti-Infective Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Lingrui OTC Anti-Infective Drug Product Portfolio Table 50. Lingrui Recent Development Table 51. Sun Pharma Company Information Table 52. Sun Pharma Business Overview Table 53. Sun Pharma OTC Anti-Infective Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Sun Pharma OTC Anti-Infective Drug Product Portfolio Table 55. Sun Pharma Recent Development Table 56. Bayer Company Information Table 57. Bayer Business Overview Table 58. Bayer OTC Anti-Infective Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Bayer OTC Anti-Infective Drug Product Portfolio Table 60. Bayer Recent Development Table 61. GSK Company Information Table 62. GSK Business Overview Table 63. GSK OTC Anti-Infective Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. GSK OTC Anti-Infective Drug Product Portfolio Table 65. GSK Recent Development Table 66. MYLAN Company Information Table 67. MYLAN Business Overview Table 68. MYLAN OTC Anti-Infective Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. MYLAN OTC Anti-Infective Drug Product Portfolio Table 70. MYLAN Recent Development Table 71. NOVARTIS Company Information Table 72. NOVARTIS Business Overview Table 73. NOVARTIS OTC Anti-Infective Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. NOVARTIS OTC Anti-Infective Drug Product Portfolio Table 75. NOVARTIS Recent Development Table 76. Johnson & Johnson Company Information Table 77. Johnson & Johnson Business Overview Table 78. Johnson & Johnson OTC Anti-Infective Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Johnson & Johnson OTC Anti-Infective Drug Product Portfolio Table 80. Johnson & Johnson Recent Development Table 81. Teva Company Information Table 82. Teva Business Overview Table 83. Teva OTC Anti-Infective Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Teva OTC Anti-Infective Drug Product Portfolio Table 85. Teva Recent Development Table 86. North America OTC Anti-Infective Drug Market Size by Type (2021-2026) & (US$ Million) Table 87. North America OTC Anti-Infective Drug Market Size by Type (2027-2032) & (US$ Million) Table 88. North America OTC Anti-Infective Drug Market Size by Application (2021-2026) & (US$ Million) Table 89. North America OTC Anti-Infective Drug Market Size by Application (2027-2032) & (US$ Million) Table 90. North America OTC Anti-Infective Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America OTC Anti-Infective Drug Market Size by Country (2021-2026) Table 92. North America OTC Anti-Infective Drug Market Size by Country (2027-2032) Table 93. Europe OTC Anti-Infective Drug Market Size by Type (2021-2026) & (US$ Million) Table 94. Europe OTC Anti-Infective Drug Market Size by Type (2027-2032) & (US$ Million) Table 95. Europe OTC Anti-Infective Drug Market Size by Application (2021-2026) & (US$ Million) Table 96. Europe OTC Anti-Infective Drug Market Size by Application (2027-2032) & (US$ Million) Table 97. Europe OTC Anti-Infective Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe OTC Anti-Infective Drug Market Size by Country (2021-2026) Table 99. Europe OTC Anti-Infective Drug Market Size by Country (2027-2032) Table 100. China OTC Anti-Infective Drug Market Size by Type (2021-2026) & (US$ Million) Table 101. China OTC Anti-Infective Drug Market Size by Type (2027-2032) & (US$ Million) Table 102. China OTC Anti-Infective Drug Market Size by Application (2021-2026) & (US$ Million) Table 103. China OTC Anti-Infective Drug Market Size by Application (2027-2032) & (US$ Million) Table 104. Asia OTC Anti-Infective Drug Market Size by Type (2021-2026) & (US$ Million) Table 105. Asia OTC Anti-Infective Drug Market Size by Type (2027-2032) & (US$ Million) Table 106. Asia OTC Anti-Infective Drug Market Size by Application (2021-2026) & (US$ Million) Table 107. Asia OTC Anti-Infective Drug Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia OTC Anti-Infective Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia OTC Anti-Infective Drug Market Size by Country (2021-2026) Table 110. Asia OTC Anti-Infective Drug Market Size by Country (2027-2032) Table 111. South America, Middle East & Africa OTC Anti-Infective Drug Market Size by Type (2021-2026) & (US$ Million) Table 112. South America, Middle East & Africa OTC Anti-Infective Drug Market Size by Type (2027-2032) & (US$ Million) Table 113. South America, Middle East & Africa OTC Anti-Infective Drug Market Size by Application (2021-2026) & (US$ Million) Table 114. South America, Middle East & Africa OTC Anti-Infective Drug Market Size by Application (2027-2032) & (US$ Million) Table 115. South America, Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. South America, Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2021-2026) Table 117. South America, Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. OTC Anti-Infective Drug Product Image Figure 2. Global OTC Anti-Infective Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global OTC Anti-Infective Drug Market Share by Type: 2025 VS 2032 Figure 4. Antiviral Image Figure 5. Antibacterial Image Figure 6. Antifungal Image Figure 7. Antiseptics Image Figure 8. Other Image Figure 9. Global OTC Anti-Infective Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global OTC Anti-Infective Drug Market Share by Application: 2025 VS 2032 Figure 11. Retail Pharmacies Image Figure 12. Online Pharmacies Image Figure 13. Hospital Pharmacies Image Figure 14. Global OTC Anti-Infective Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 16. Global OTC Anti-Infective Drug Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global OTC Anti-Infective Drug Market Share by Players in 2025 Figure 19. Global Top 5 and 10 OTC Anti-Infective Drug Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global OTC Anti-Infective Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global OTC Anti-Infective Drug Revenue Market Share by Type (2021-2032) Figure 23. Global OTC Anti-Infective Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global OTC Anti-Infective Drug Revenue Market Share by Application (2021-2032) Figure 25. North America OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 26. North America OTC Anti-Infective Drug Market Share by Type (2021-2032) Figure 27. North America OTC Anti-Infective Drug Market Share by Application (2021-2032) Figure 28. North America OTC Anti-Infective Drug Market Share by Country (2021-2032) Figure 29. United States OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 30. Canada OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 31. Mexico OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 32. Europe OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 33. Europe OTC Anti-Infective Drug Market Share by Type (2021-2032) Figure 34. Europe OTC Anti-Infective Drug Market Share by Application (2021-2032) Figure 35. Europe OTC Anti-Infective Drug Market Share by Country (2021-2032) Figure 36. Germany OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 37. France OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 38. U.K. OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 39. Italy OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 40. Russia OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 42. China OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 43. China OTC Anti-Infective Drug Market Share by Type (2021-2032) Figure 44. China OTC Anti-Infective Drug Market Share by Application (2021-2032) Figure 45. Asia OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 46. Asia OTC Anti-Infective Drug Market Share by Type (2021-2032) Figure 47. Asia OTC Anti-Infective Drug Market Share by Application (2021-2032) Figure 48. Asia OTC Anti-Infective Drug Market Share by Country (2021-2032) Figure 49. Japan OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 50. South Korea OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 53. India OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 54. Australia OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa OTC Anti-Infective Drug Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa OTC Anti-Infective Drug Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa OTC Anti-Infective Drug Market Share by Country (2021-2032) Figure 59. Brazil OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 60. South Africa OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 62. Turkey OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 63. Argentina OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 64. UAE OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 65. Egypt OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 66. Chile OTC Anti-Infective Drug Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Antiviral
  • Antibacterial
  • Antifungal
  • Antiseptics
  • Other
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Cipla
  • CR SANJIU
  • Lingrui
  • Sun Pharma
  • Bayer
  • GSK
  • MYLAN
  • NOVARTIS
  • Johnson & Johnson
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global OTC Anti-Infective Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Antiviral
  5. 1.2.3 Antibacterial
  6. 1.2.4 Antifungal
  7. 1.2.5 Antiseptics
  8. 1.2.6 Other
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global OTC Anti-Infective Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Retail Pharmacies
  12. 1.3.3 Online Pharmacies
  13. 1.3.4 Hospital Pharmacies
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global OTC Anti-Infective Drug Growth Trends by Region
  16. 1.5.1 Global OTC Anti-Infective Drug Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 OTC Anti-Infective Drug Market Size by Region (2021-2026)
  18. 1.5.3 OTC Anti-Infective Drug Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global OTC Anti-Infective Drug Market Dynamics
  1. 2.1 OTC Anti-Infective Drug Industry Trends
  2. 2.2 OTC Anti-Infective Drug Industry Drivers
  3. 2.3 OTC Anti-Infective Drug Industry Opportunities and Challenges
  4. 2.4 OTC Anti-Infective Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global OTC Anti-Infective Drug Revenue by Company (2021-2026)
  2. 3.2 Global OTC Anti-Infective Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global OTC Anti-Infective Drug Key Company Head office and Area Served
  4. 3.4 Global OTC Anti-Infective Drug Company, Product Type & Application
  5. 3.5 Global OTC Anti-Infective Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global OTC Anti-Infective Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 OTC Anti-Infective Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 OTC Anti-Infective Drug Tier 1, Tier 2, and Tier 3
4 OTC Anti-Infective Drug Market by Type
  1. 4.1 Global OTC Anti-Infective Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global OTC Anti-Infective Drug Market Size by Type (2021-2032)
  3. 4.3 Global OTC Anti-Infective Drug Market Size Share by Type (2021-2032)
5 OTC Anti-Infective Drug Market by Application
  1. 5.1 Global OTC Anti-Infective Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global OTC Anti-Infective Drug Market Size by Application (2021-2032)
  3. 5.3 Global OTC Anti-Infective Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Cipla
  2. 6.1.1 Cipla Company Information
  3. 6.1.2 Cipla Business Overview
  4. 6.1.3 Cipla OTC Anti-Infective Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Cipla OTC Anti-Infective Drug Product Portfolio
  6. 6.1.5 Cipla Recent Developments
  7. 6.2 CR SANJIU
  8. 6.2.1 CR SANJIU Company Information
  9. 6.2.2 CR SANJIU Business Overview
  10. 6.2.3 CR SANJIU OTC Anti-Infective Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 CR SANJIU OTC Anti-Infective Drug Product Portfolio
  12. 6.2.5 CR SANJIU Recent Developments
  13. 6.3 Lingrui
  14. 6.3.1 Lingrui Company Information
  15. 6.3.2 Lingrui Business Overview
  16. 6.3.3 Lingrui OTC Anti-Infective Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Lingrui OTC Anti-Infective Drug Product Portfolio
  18. 6.3.5 Lingrui Recent Developments
  19. 6.4 Sun Pharma
  20. 6.4.1 Sun Pharma Company Information
  21. 6.4.2 Sun Pharma Business Overview
  22. 6.4.3 Sun Pharma OTC Anti-Infective Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Sun Pharma OTC Anti-Infective Drug Product Portfolio
  24. 6.4.5 Sun Pharma Recent Developments
  25. 6.5 Bayer
  26. 6.5.1 Bayer Company Information
  27. 6.5.2 Bayer Business Overview
  28. 6.5.3 Bayer OTC Anti-Infective Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Bayer OTC Anti-Infective Drug Product Portfolio
  30. 6.5.5 Bayer Recent Developments
  31. 6.6 GSK
  32. 6.6.1 GSK Company Information
  33. 6.6.2 GSK Business Overview
  34. 6.6.3 GSK OTC Anti-Infective Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 GSK OTC Anti-Infective Drug Product Portfolio
  36. 6.6.5 GSK Recent Developments
  37. 6.7 MYLAN
  38. 6.7.1 MYLAN Company Information
  39. 6.7.2 MYLAN Business Overview
  40. 6.7.3 MYLAN OTC Anti-Infective Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 MYLAN OTC Anti-Infective Drug Product Portfolio
  42. 6.7.5 MYLAN Recent Developments
  43. 6.8 NOVARTIS
  44. 6.8.1 NOVARTIS Company Information
  45. 6.8.2 NOVARTIS Business Overview
  46. 6.8.3 NOVARTIS OTC Anti-Infective Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 NOVARTIS OTC Anti-Infective Drug Product Portfolio
  48. 6.8.5 NOVARTIS Recent Developments
  49. 6.9 Johnson & Johnson
  50. 6.9.1 Johnson & Johnson Company Information
  51. 6.9.2 Johnson & Johnson Business Overview
  52. 6.9.3 Johnson & Johnson OTC Anti-Infective Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Johnson & Johnson OTC Anti-Infective Drug Product Portfolio
  54. 6.9.5 Johnson & Johnson Recent Developments
  55. 6.10 Teva
  56. 6.10.1 Teva Company Information
  57. 6.10.2 Teva Business Overview
  58. 6.10.3 Teva OTC Anti-Infective Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Teva OTC Anti-Infective Drug Product Portfolio
  60. 6.10.5 Teva Recent Developments
7 North America
  1. 7.1 North America OTC Anti-Infective Drug Market Size (2021-2032)
  2. 7.2 North America OTC Anti-Infective Drug Market Size by Type
  3. 7.2.1 North America OTC Anti-Infective Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America OTC Anti-Infective Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America OTC Anti-Infective Drug Market Share by Type (2021-2032)
  6. 7.3 North America OTC Anti-Infective Drug Market Size by Application
  7. 7.3.1 North America OTC Anti-Infective Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America OTC Anti-Infective Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America OTC Anti-Infective Drug Market Share by Application (2021-2032)
  10. 7.4 North America OTC Anti-Infective Drug Market Size by Country
  11. 7.4.1 North America OTC Anti-Infective Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America OTC Anti-Infective Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America OTC Anti-Infective Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America OTC Anti-Infective Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe OTC Anti-Infective Drug Market Size (2021-2032)
  2. 8.2 Europe OTC Anti-Infective Drug Market Size by Type
  3. 8.2.1 Europe OTC Anti-Infective Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe OTC Anti-Infective Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe OTC Anti-Infective Drug Market Share by Type (2021-2032)
  6. 8.3 Europe OTC Anti-Infective Drug Market Size by Application
  7. 8.3.1 Europe OTC Anti-Infective Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe OTC Anti-Infective Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe OTC Anti-Infective Drug Market Share by Application (2021-2032)
  10. 8.4 Europe OTC Anti-Infective Drug Market Size by Country
  11. 8.4.1 Europe OTC Anti-Infective Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe OTC Anti-Infective Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe OTC Anti-Infective Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe OTC Anti-Infective Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China OTC Anti-Infective Drug Market Size (2021-2032)
  2. 9.2 China OTC Anti-Infective Drug Market Size by Type
  3. 9.2.1 China OTC Anti-Infective Drug Market Size by Type (2021-2026)
  4. 9.2.2 China OTC Anti-Infective Drug Market Size by Type (2027-2032)
  5. 9.2.3 China OTC Anti-Infective Drug Market Share by Type (2021-2032)
  6. 9.3 China OTC Anti-Infective Drug Market Size by Application
  7. 9.3.1 China OTC Anti-Infective Drug Market Size by Application (2021-2026)
  8. 9.3.2 China OTC Anti-Infective Drug Market Size by Application (2027-2032)
  9. 9.3.3 China OTC Anti-Infective Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia OTC Anti-Infective Drug Market Size (2021-2032)
  2. 10.2 Asia OTC Anti-Infective Drug Market Size by Type
  3. 10.2.1 Asia OTC Anti-Infective Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia OTC Anti-Infective Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia OTC Anti-Infective Drug Market Share by Type (2021-2032)
  6. 10.3 Asia OTC Anti-Infective Drug Market Size by Application
  7. 10.3.1 Asia OTC Anti-Infective Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia OTC Anti-Infective Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia OTC Anti-Infective Drug Market Share by Application (2021-2032)
  10. 10.4 Asia OTC Anti-Infective Drug Market Size by Country
  11. 10.4.1 Asia OTC Anti-Infective Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia OTC Anti-Infective Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia OTC Anti-Infective Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia OTC Anti-Infective Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa OTC Anti-Infective Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa OTC Anti-Infective Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa OTC Anti-Infective Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa OTC Anti-Infective Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa OTC Anti-Infective Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa OTC Anti-Infective Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa OTC Anti-Infective Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa OTC Anti-Infective Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa OTC Anti-Infective Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa OTC Anti-Infective Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa OTC Anti-Infective Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst